Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Gene Expression Profiling Reveals Two Overarching Types of Anaplastic Large Cell Lymphoma with Distinct Targetable Biology: An L.L.M.P.P. Study

Blood (2023) 142 (Supplement 1): 847.

https://doi.org/10.1182/blood-2023-186969

Published: 2023

Journal Articles

Single Cell Multi Omics and Spatial Analysis Reveals Plasmablast Signature Malignant Cells As a Key of Intratumor Heterogeneity in Primary Central Nervous System Lymphoma

Blood (2023) 142 (Supplement 1): 2998.

https://doi.org/10.1182/blood-2023-174410

Published: 2023

Journal Articles

Final Analysis of the Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab for DLBCL: JCOG0601

Blood (2023) 142 (Supplement 1): 1724.

https://doi.org/10.1182/blood-2023-178551

Published: 2023

Journal Articles

Clinical Impact of Cell-of-Origin and Double-Hit Signature of DLBCL in Japan

Blood (2022) 140 (Supplement 1): 6421–6423.

https://doi.org/10.1182/blood-2022-157702

Published: 2022

Journal Articles

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elias Campo, Elaine S. Jaffe, James R. Cook, Leticia Quintanilla-Martinez, Steven H. Swerdlow, Kenneth C. Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L. Feldman, Falko Fend, Jonathan W. Friedberg, Philippe Gaulard, Paolo Ghia, Steven M. Horwitz, Rebecca L. King, Gilles Salles, Jesus San-Miguel, John F. Seymour, Steven P. Treon, Julie M. Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Leif Bergsagel, Wing C. Chan, Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando Lopez-Guillermo, Maria Victoria Mateos, Elizabeth Macintyre, Ari M. Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A. Pileri, Miguel Piris, Barbara Pro, Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier-Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz

Blood (2022) 140 (11): 1229–1253.

https://doi.org/10.1182/blood.2022015851

Published: 2022

Includes: Supplemental data

Journal Articles

Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab (RW-CHOP) for Previously Untreated DLBCL: JCOG0601

Blood (2018) 132 (Supplement 1): 4194.

https://doi.org/10.1182/blood-2018-99-110201

Published: 2018

Journal Articles

Ten-Year Follow-up of Newly Diagnosed Follicular Lymphoma Patients Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) As First-Line Therapy in JCOG0203 Trial

Takashi Watanabe, MDPhD, Kensei Tobinai, MD, PhD, Masashi Wakabayashi, MSc, Yasuo Morishima, MDPhD, Hirobumi Kobayashi, MD PhD, Tomohiro Kinoshita, MD PhD, Takayo Suzuki, MD PhD, Motoko Yamaguchi, MDPhD, Kiyoshi Ando, MD PhD, Michinori Ogura, MD PhD, Masafumi Taniwaki, MD PhD, Naokuni Uike, MD, PhD, Tadashi Yoshino, MD PhD, Shigeru Nawano, MD PhD, Takashi Terauchi, MD PhD, Tomomitsu Hotta, MD PhD, Kunihiro Tsukasaki, MD PhD

Blood (2017) 130 (Supplement 1): 5168.

https://doi.org/10.1182/blood.V130.Suppl_1.5168.5168

Published: 2017

Journal Articles

Structural Variations Involving Programmed Death Ligands in B-Cell and T-Cell Lymphomas

Keisuke Kataoka, MD PhD, Hiroaki Miyoshi, MD PhD, Yasunori Kogure, MD, Yasuharu Sato, MD PhD, Kenji Nishida, MD, Yuichi Shiraishi, PhD, Hiroko Tanaka, BA, Kenichi Chiba, BA, Yosaku Watatani, MD, Yusuke Shiozawa, MD, Kenichi Yoshida, MD PhD, Masashi Sanada, MD PhD, Motohiro Kato, MD PhD, Satoru Miyano, PhD, Koji Izutsu, MD PhD, Kengo Takeuchi, MD PhD, Tadashi Yoshino, MD PhD, Koichi Ohshima, MD PhD, Seishi Ogawa, MD PhD

Blood (2016) 128 (22): 4105.

https://doi.org/10.1182/blood.V128.22.4105.4105

Published: 2016

Journal Articles

Dose-Adjusted EPOCH Chemotherapy for Untreated Peripheral T-Cell Lymphomas: Multicenter Phase II Trial of West-Jhog PTCL0707

Yoshinobu Maeda, MD PhD, Hisakazu Nishimori, MD PhD, Yasushi Hiramatsu, Isao Yoshida, Masatoshi Uno, Yasufumi Masaki, MD PhD, Kazutaka Sunami, MD PhD, Taro Masunari, Yuichiro Nawa, Hiroshi Gomyo, Hiromichi Yamane, Tsutomu Takahashi, MD PhD, Tomofumi Yano, Hidetaka Takimoto, MD, Keitaro Matsuo, MD PhD, Tadashi Yoshino, MD PhD, Mitsune Tanimoto, MD PhD

Blood (2016) 128 (22): 5349.

https://doi.org/10.1182/blood.V128.22.5349.5349

Published: 2016

Journal Articles

Molecular Heterogeneity in Peripheral T-Cell Lymphoma Not Otherwise Specified Revealed By Comprehensive Mutational Profiling

Yosaku Watatani, MD, Yasuharu Sato, MD PhD, Kenji Nishida, MD, Hiroaki Miyoshi, MD PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, BA, Tanaka Hiroko, Hiroo Ueno, MD, Nobuyuki Kakiuchi, MD, Yusuke Shiozawa, MD, Tetsuichi Yoshizato, MD PhD, Kenichi Yoshida, MD PhD, Masashi Sanada, MD PhD, Satoru Miyano, PhD, Koichi Ohshima, MD PhD, Tadashi Yoshino, MD PhD, Seishi Ogawa, MD PhD, Keisuke Kataoka, MD PhD

Blood (2016) 128 (22): 2927.

https://doi.org/10.1182/blood.V128.22.2927.2927

Published: 2016

Journal Articles

Identification of TRA-1-60-Positive Cells As a Potent Refractory Population in Follicular Lymphomas

Katsuyoshi Takata, MD, PhD, Hidekazu Iioka, Tomoko Miyata-Takata, Yukari Miki, Tadashi Yoshino, MD PhD, Yoshinobu Maeda, MD PhD, Ken Saito, Christian Steidl, Eisaku Kondo

Blood (2016) 128 (22): 4122.

https://doi.org/10.1182/blood.V128.22.4122.4122

Published: 2016

Journal Articles

Prognostic Significance of EBV Association in Diffuse Large B-Cell Lymphoma in the Rituximab Era

Nozomi Niitsu, MDPhD, Naoki Takahashi, Tadashi Yoshino, MD PhD, Masataka Okamoto, MD PhD, Shigeo Nakamura, MD PhD

Blood (2015) 126 (23): 3911.

https://doi.org/10.1182/blood.V126.23.3911.3911

Published: 2015

Journal Articles

Prognostic Value Of LMP1, CLA, NK-Cell Origin, and Pretreatment Bone Marrow EBER-ISH In Localized NK/T-Cell Lymphoma Prospectively Treated With Concurrent Chemoradiotherapy: An Ancillary Study Of Japan Clinical Oncology Group (JCOG) 0211

Motoko Yamaguchi, MD, PhD, Katsuyoshi Takata, MD, PhD, Tadashi Yoshino, MD, PhD, Naoki Ishizuka, PhD, Masahiko Oguchi, MD, PhD, Yukio Kobayashi, MD, PhD, Yasushi Isobe, MD, PhD, Kenichi Ishizawa, MD, Nobuko Kubota, MD, PhD, Kuniaki Itoh, MD, PhD, Noriko Usui, MD, PhD, Kana Miyazaki, MD, PhD, Izumi Wasada, RN, Shigeo Nakamura, MD, PhD, Yoshihiro Matsuno, MD, PhD, Kazuo Oshimi, MD, PhD, Tomohiro Kinoshita, MD, PhD, Kunihiro Tsukasaki, MD, PhD, Kensei Tobinai, MD, PhD

Blood (2013) 122 (21): 4280.

https://doi.org/10.1182/blood.V122.21.4280.4280

Published: 2013

Journal Articles

Serum IL-10 and IL-8 Among Variable Cytokines Derived From Helper T Cells Might Be Associated with Prognoses for Malignant Lymphoma Patients

Junichi Kitagawa, MD, PhD, Hisashi Tsurumi, MD, PhD, Naoe Goto, MD, PhD, Katsuyoshi Takata, MD, PhD, Nobuhiko Nakamura, MD, Nobuhiro Kanemura, MD, PhD, Takeshi Hara, MD, PhD, Senji Kasahara, MD, PhD, Takeshi Takahashi, MD, PhD, Tadashi Yoshino, Prof., Hisataka Moriwaki, Prof.

Blood (2012) 120 (21): 5107.

https://doi.org/10.1182/blood.V120.21.5107.5107

Published: 2012

Journal Articles

Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17

Hisakazu Nishimori, Yoshinobu Maeda, Takanori Teshima, Haruko Sugiyama, Koichiro Kobayashi, Yoshiko Yamasuji, Sachiyo Kadohisa, Hidetaka Uryu, Kengo Takeuchi, Takehiro Tanaka, Tadashi Yoshino, Yoichiro Iwakura, Mitsune Tanimoto

Blood (2012) 119 (1): 285–295.

https://doi.org/10.1182/blood-2011-01-332478

Published: 2012

Includes: Supplemental data

Journal Articles

Clinical Significance of Immunohistochemical Markers of Diffuse Large B-Cell Lymphoma In the Rituximab Era.

Miyuki Hayama, Masataka Okamoto, MD, PhD, Yuki Hagiwara, Ken Tanae, Mika Kohri, Naoki Takahashi, Tadashi Yoshino, Koichi Ohshima, Nozomi Niitsu, MD

Blood (2010) 116 (21): 1800.

https://doi.org/10.1182/blood.V116.21.1800.1800

Published: 2010

Journal Articles

Nuclear Area Predicts Outcome In Peripheral T-Cell Lymphoma, Not Otherwise Specified: Morphometric Image and Immunohistochemical Analyses of 78 Patients

Daisuke Niino, MD, Yoshizo Kimura, MD, Junichi Kiyasu, MD, Masanori Takeuchi, MD, Tadashi Yoshino, MD, Shigeo Nakamura, MD, Koichi Ohshima, MD

Blood (2010) 116 (21): 5081.

https://doi.org/10.1182/blood.V116.21.5081.5081

Published: 2010

Journal Articles

Clinicopathological Features of Nodular Sclerosis-Type Classical Hodgkin Lymphoma In the Elderly: Multicenter Study of Hodgkin Lymphoma In Japan

Naoko Asano, MD, Tomohiro Kinoshita, MD, PhD, Koichi Ohshima, MD, Tadashi Yoshino, MD, Nozomi Niitsu, MD, Norifumi Tsukamoto, MD, PhD, Kaoru Hirabayashi, MD, Koji Izutsu, MD, Yasuo Morishima, MD, PhD, Tadashi Matsushita, MD, PhD, Shigeo Nakamura, MD

Blood (2010) 116 (21): 2677.

https://doi.org/10.1182/blood.V116.21.2677.2677

Published: 2010

Journal Articles

Cytotoxic Molecule (CM)-Positive Classical Hodgkin Lymphoma: a Clinicopathologic Study in Comparison with Nodal Peripheral T-Cell Lymphoma of Not Otherwise Specified Type Possessing CM Expression.

Naoko Asano, MD, PhD, Jun-Ichi Tamaru, MD, PhD, Fumihiro Ishida, MD, PhD, Tadashi Yoshino, MD, PhD, Yoshitoyo Kagami, MD, PhD, Yasuo Morishima, MD, PhD, Masao Seto, MD, PhD, Tomohiro Kinoshita, MD, PhD, Shigeo Nakamura, MD, PhD

Blood (2009) 114 (22): 1549.

https://doi.org/10.1182/blood.V114.22.1549.1549

Published: 2009

Journal Articles

Aberrations of Genes Regulating NF Kappa B Pathway in B-Cell Malignant Lymphoma.

Blood (2009) 114 (22): 971.

https://doi.org/10.1182/blood.V114.22.971.971

Published: 2009

NARROW

Gene Expression Profiling Reveals Two Overarching Types of Anaplastic Large Cell Lymphoma with Distinct Targetable Biology: An L.L.M.P.P. Study

Single Cell Multi Omics and Spatial Analysis Reveals Plasmablast Signature Malignant Cells As a Key of Intratumor Heterogeneity in Primary Central Nervous System Lymphoma

Final Analysis of the Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab for DLBCL: JCOG0601

Clinical Impact of Cell-of-Origin and Double-Hit Signature of DLBCL in Japan

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab (RW-CHOP) for Previously Untreated DLBCL: JCOG0601

Ten-Year Follow-up of Newly Diagnosed Follicular Lymphoma Patients Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) As First-Line Therapy in JCOG0203 Trial

Structural Variations Involving Programmed Death Ligands in B-Cell and T-Cell Lymphomas

Dose-Adjusted EPOCH Chemotherapy for Untreated Peripheral T-Cell Lymphomas: Multicenter Phase II Trial of West-Jhog PTCL0707

Molecular Heterogeneity in Peripheral T-Cell Lymphoma Not Otherwise Specified Revealed By Comprehensive Mutational Profiling

Identification of TRA-1-60-Positive Cells As a Potent Refractory Population in Follicular Lymphomas

Prognostic Significance of EBV Association in Diffuse Large B-Cell Lymphoma in the Rituximab Era

Prognostic Value Of LMP1, CLA, NK-Cell Origin, and Pretreatment Bone Marrow EBER-ISH In Localized NK/T-Cell Lymphoma Prospectively Treated With Concurrent Chemoradiotherapy: An Ancillary Study Of Japan Clinical Oncology Group (JCOG) 0211

Serum IL-10 and IL-8 Among Variable Cytokines Derived From Helper T Cells Might Be Associated with Prognoses for Malignant Lymphoma Patients

Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17

Clinical Significance of Immunohistochemical Markers of Diffuse Large B-Cell Lymphoma In the Rituximab Era.

Nuclear Area Predicts Outcome In Peripheral T-Cell Lymphoma, Not Otherwise Specified: Morphometric Image and Immunohistochemical Analyses of 78 Patients

Clinicopathological Features of Nodular Sclerosis-Type Classical Hodgkin Lymphoma In the Elderly: Multicenter Study of Hodgkin Lymphoma In Japan

Cytotoxic Molecule (CM)-Positive Classical Hodgkin Lymphoma: a Clinicopathologic Study in Comparison with Nodal Peripheral T-Cell Lymphoma of Not Otherwise Specified Type Possessing CM Expression.

Aberrations of Genes Regulating NF Kappa B Pathway in B-Cell Malignant Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only